Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.597,41
-1,10%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Athira Pharma Inc (ATHA) Athira Pharma Inc (ATHA) Notizie

Athira Pharma Inc

ATHA
1,99
0,02 (1,02%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/4/202413:00GLOBEAthira Pharma Appoints Javier San Martin, M.D., as Chief..
11/4/202413:00GLOBEAthira Pharma Announces Publication of Preclinical Data..
03/4/202413:00GLOBEAthira Pharma Announces Upcoming Poster Presentation at..
08/3/202413:00GLOBEAthira Pharma Presents Clinical and Preclinical Data..
22/2/202422:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202422:10EDGAR2Form 8-K - Current report
22/2/202422:05GLOBEAthira Pharma Reports Full Year 2023 Financial Results and..
16/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:40EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
08/2/202422:02GLOBEAthira Pharma Announces Publication in Frontiers in..
08/1/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202413:11EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEAthira Pharma Provides 2024 Clinical Pipeline Outlook and..
03/1/202413:00GLOBEAthira Pharma Completes Enrollment of Phase 2/3 LIFT-AD..
12/12/202313:00GLOBEAthira Pharma Announces Encouraging Results from SHAPE Phase..
29/11/202313:00GLOBEAthira Pharma to Participate in Sidoti December Small Cap..
28/11/202313:00GLOBEAthira Pharma Announces Upcoming Presentation at Motor..
15/11/202314:15GLOBEAthira Pharma Presents Preclinical Data Highlighting..
09/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:10EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEAthira Pharma Reports Third Quarter 2023 Financial Results..
08/11/202313:00GLOBEAthira Pharma to Participate in Jefferies London Healthcare..
05/10/202322:30GLOBEAthira Pharma Presents Preclinical Data Further Supporting..
28/9/202313:00GLOBEAthira Pharma to Participate in Upcoming October Conferences
19/9/202313:00GLOBEAthira Pharma to Participate in the 2023 Cantor Fitzgerald..
10/8/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:10EDGAR2Form 8-K - Current report
10/8/202322:05GLOBEAthira Pharma Reports Second Quarter 2023 Financial Results..
17/7/202313:00GLOBEAthira Pharma Presents Phase 2 Clinical Data Correlating..
06/7/202313:00GLOBEAthira Pharma Announces Upcoming Presentations at the..
31/5/202313:00GLOBEAthira Pharma to Participate in Upcoming June Conferences
22/5/202313:00GLOBEAthira Pharma Appoints Andrew Gengos as Chief Financial..
11/5/202322:05GLOBEAthira Pharma Reports First Quarter 2023 Financial Results..
08/5/202313:00GLOBEAthira Pharma to Participate in Upcoming May Investor..
Apertura: 2,00 Min: 1,99 Max: 2,05
Chiusura: 1,97

La tua Cronologia

NASDAQ
ATHA
Athira Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network